cadexomer iodine

01/01/2017 - "Cadexomer iodine (CI) was recently reported to have superior efficacy compared to diverse wound dressings against Pseudomonas aeruginosa biofilms in an ex vivo model. "
01/01/2017 - "Cadexomer iodine provides superior efficacy against bacterial wound biofilms in vitro and in vivo."
02/01/1999 - "Cadexomer iodine may be an effective agent for preventing proliferation of MRSA in wounds."
10/01/2021 - "Efficacy of topical cadexomer iodine treatment in chronic wounds: Systematic review and meta-analysis of comparative clinical trials."
03/01/2002 - "These studies demonstrate that cadexomer iodine has definite non-toxic concentration ranges for fibroblasts in vitro, which are consistent with a lack of cellular toxicity in human chronic exudative wounds treated with cadexomer iodine. "

08/01/1983 - "There was a significant reduction of ulcer area with both treatments within three weeks; however, eight of 16 patients treated with cadexomer iodine had a reduction of ulcer area of more than 50 per cent, compared with one of 18 patients treated with the standard treatment (P less than 0.01). "
03/01/2019 - "This study compares the safety and efficacy of 2 formulations of cadexomer iodine and standard care for the treatment of chronic ulcers. "
03/01/2019 - "Efficacy of Cadexomer Iodine in the Treatment of Chronic Ulcers: A Randomized, Multicenter, Controlled Trial."
07/01/1983 - "With standard treatment the mean ulcer size increased slightly during the 6-week trial whereas with cadexomer iodine the ulcer size was significantly reduced. "
03/01/2019 - "These results demonstrate that cadexomer iodine, in comparison with standard care alone, increases the percentage of reduction in ulcer size and promotes complete wound healing in chronic ulcers."

06/01/2016 - "Estimating the Clinical Outcomes and Cost Differences Between Standard Care With and Without Cadexomer Iodine in the Management of Chronic Venous Leg Ulcers Using a Markov Model."
04/01/1997 - "The clinical and bacteriological efficacy of topical cadexomer iodine on venous leg ulcers colonised with Pseudomonas aeruginosa was evaluated in an open, uncontrolled, multicentre pilot study. "
09/01/1986 - "A study of the effect of cadexomer iodine in the treatment of venous leg ulcers."
06/01/2001 - "Cadexomer-iodine in the treatment of venous leg ulcers: what is the evidence?"
03/08/2001 - "A case study describes the use of Iodoflex in a difficult-to-heal venous leg ulcer."

07/01/1983 - "A randomized trial comparing cadexomer iodine and standard treatment in the out-patient management of chronic venous ulcers."
09/28/1985 - "Controlled trial of Iodosorb in chronic venous ulcers."
08/31/1985 - "Controlled trial of Iodosorb in chronic venous ulcers."
08/03/1985 - "Controlled trial of Iodosorb in chronic venous ulcers."
07/01/1989 - "Multicenter trial of cadexomer iodine to treat venous stasis ulcer."

11/16/2020 - "Animals that received treatment with AKIG patches and Iodoflex showed better infection containment as compared to that with Tegaderm-covered control and exhibited complete healing. "
11/07/2020 - "Patient who did not use cadexomer iodine experienced twice as many infections (64% vs 32%;p = 0.010). "
11/07/2020 - "Reduction of pin tract infections during external fixation using cadexomer iodine."
12/01/2019 - "Cadexomer Iodine reduces the total microbial load in DFUs with chronic biofilm infections and affects microbial community composition and diversity. "
10/01/2021 - "The aim of this study was to summarise the clinical evidence supporting almost 40 years of topical cadexomer iodine (CIOD) use in wound bed preparation by removing barriers to healing such as exudate, slough, bioburden, and infection and allowing chronic wound progression. "